Found 6 matching trials
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
PHASE1The purpose of this phase 1b study is to evaluate the safety and tolerabili...
Location
Arkansas Children's Hospital
Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children
PHASE3Open-label, follow-up study for subjects who completed the EPITOPE study....
Location
Banner University Medical Center Tucson
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
PHASE3The primary objective of this study is to assess the 6-month safety of DBV7...
Status
Active Not Recruiting
Location
AllerVie Clinical Research
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age
PHASE3The primary purpose of this study is to assess the efficacy and safety of d...
Status
Active Not Recruiting
Location
DBV Investigative Site
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
PHASE2Food allergy occurs when the immune system reacts against foods. The immune...
Location
Arkansas Children's Hospital
Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children
N/AThis is an open label expanded access program for male and female patients ...
Location
Early Access Care, LLC